Instituto Nacional do Câncer

Recent papers from Instituto Nacional do Câncer

1. Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysisFrontiers in Oncology · 2026
2. Complete blood count–based risk stratification to support lung cancer screening in resource-limited settings: a retrospective cohort analysisScientific Reports · 2026
3. Implications of Age and Parity on Squamocolumnar Junction (SCJ) Visibility for Implementing Artificial Intelligence-Assisted Cervical Cancer Screening: Multi-Country Evidence From the PAVE StudyJCO Global Oncology · 2026
4. Racial disparities in cancer burden, care pathways, and mortality among women in Brazil: a nationwide real-world analysisESMO Real World Data and Digital Oncology · 2026
5. Exercise preconditioning mitigates colon carcinogenesis through targeted epigenetic remodeling and suppression of early preneoplastic lesionsCarcinogenesis · 2026
6. Expert recommendations on the management of major and minor toxicities associated with the use of lorlatinib in Latin AmericaFrontiers in Oncology · 2026
7. Uncovering a hidden burden: HPV-related anal cancer risk amongst women living with HIV in Brazil, preliminary data from a cross-sectional studyInfectious Agents and Cancer · 2026
8. Combination therapies for the treatment of locally advanced and advanced cervical cancerExpert Opinion on Pharmacotherapy · 2026
9. AKT Phosphorylation of FOXK2 at Ser398 Impacts Breast Cancer Cell Growth and ViabilityThe FASEB Journal · 2026
10. FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphomaEMBO Molecular Medicine · 2026
11. Standardizing Cell Ontology terms for cross-study integration in the female reproductive tractScience Advances · 2026
12. Real-world performance of the breast GPA in breast cancer brain metastases in a resource limited settingJournal of Neuro-Oncology Discovery · 2026
13. The HEADSpAcE Data Center: An international data and biospecimen resource for head and neck cancer translational researchOpen Research Europe · 2026
14. Disitamab vedotin in urothelial carcinoma patients: a clinical trial perspective from ARON working groupExpert Review of Clinical Pharmacology · 2026
15. Aptamers as Innovative Tools for Prostate Cancer: Tumor Recognition and Biological ActivityBiomolecules · 2026
16. Low handgrip strength in advanced cancer: associated factors and clinical implications in palliative careSupportive Care in Cancer · 2026
17. IARC Perspective on Lung Cancer ScreeningNew England Journal of Medicine · 2026
18. Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgeryFuture Oncology · 2026
19. Prognostic factors associated with survival in patients with colorectal cancer treated with capecitabine: A cohort studyJournal of Oncology Pharmacy Practice · 2026
20. Electrolyte disturbances after allogeneic hematopoietic cell transplantation in patients receiving calcineurin inhibitors: incidence and severityFrontiers in Pharmacology · 2026